Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 3
4(57.1%)
N/A
3(42.9%)
7Total
Phase 3(4)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)